Peter S Grimison

18PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 29, 2026
A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma.

Matthew Youssef, Peter Grimison

|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Jul 02, 2025
Real-World Clinical Utility of Tumor Next-Generation Sequencing in Adolescent and Young Adult Patients With Sarcoma.

Karan Gupta, Peter Grimison, Karl Fernandez

|Mar 25, 2025
Real-World Experience Using Brigimadlin (MDM2 Inhibitor) in an Australian Sarcoma Specialist Center Compared to Pivotal Clinical Trial Results.

Karan Gupta, Peter Grimison

|Nov 18, 2024
Real-World Outcomes of Patients Treated With Gemcitabine Using Standardized Dose and Rate and Docetaxel for Advanced Soft Tissue Sarcoma in an Australian Sarcoma Center.

Isabella Wilson, Madeleine Strach, Vivek Bhadri

|Oct 11, 2024
Characteristics and outcomes among patients with delayed orchidectomy for advanced germ cell tumours.

Patrick Ngo, Nariman Ahmadi, Peter Ferguson

Pageof 3

Frequent Collaborators

3 joint publications

Aaron R Hansen

2 joint publications

Gedske Daugaard

2 joint publications

Helene Negaard

2 joint publications

Ugo De Giorgi